QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Povey, A. C. Articles by Margison, G. P. Search for Related Content PubMed PubMed Citation Articles by Povey, A. C. Articles by Margison, G. P.

---

Supplement: International Research Conference on Food, Nutrition & Cancer

DNA Alkylation and Repair in the Large Bowel: Animal and Human Studies^{1 ,2}

Andrew C. Povey³, Alaa F. Badawi^*,4, Donald P. Cooper^*,5, C. Nicholas Hall, Kathryn L. Harrison, Peta E. Jackson^*,6, Nicholas P. Lees, Peter J. O’Connor^*,7 and Geoffrey P. Margison^*

Centre for Occupational and Environmental Health, School of Epidemiology and Health Sciences, University of Manchester, Manchester, M13 9PL, ^* Cancer Research UK Carcinogenesis Group, Paterson Institute for Cancer Research, Manchester, M20 9BX and Department of General Surgery, Wythenshawe Hospital, Manchester M23 9LT, England

³To whom correspondence should be addressed. E-mail: apovey{at}man.ac.uk.

O⁶-Methylguanine (O⁶-MeG), a procarcinogenic DNA adduct that arises from exposure to methylating agents, has been detected in human colorectal DNA at levels comparable to those that cause adverse effects in model systems. O⁶-MeG levels vary within the colon, being higher in the cancer-prone regions of the large bowel. In rats and mice, O⁶-MeG persistence in colon DNA is associated with the induction of colon tumors after treatment with methylating agents. These tumors frequently contain K-ras GCAT transition mutations, which is consistent with the mutagenic properties of O⁶-MeG: such mutations are also commonly found in human colorectal cancers. O⁶-Alkylguanine adducts are removed by the DNA repair protein, O⁶-alkylguanine DNA-alkyltransferase (MGMT). MGMT overexpression in transgenic mice reduces the formation of K-ras GCAT mutations and tumors induced by methylating agents. Interindividual variations in human colon MGMT activity are large and large bowel tumors can occur in regions of low activity. Low MGMT activity in normal mucosa has been associated with the occurrence of K-ras GCAT mutations, whereas reduced MGMT expression and an increased frequency of K-ras GCAT mutations in colorectal cancers have been linked to MGMT promoter methylation. MGMT activity is also lower in adenomas than in adjacent normal tissue but only in those adenomas with this specific mutation. These results are entirely consistent with the hypothesis that GCAT mutations in the K-ras oncogene result from the formation and persistence of O⁶-alkylguanine lesions in colorectal DNA. Human exposure to endogenous or exogenous alkylating agents may thus be an environmental determinant of colorectal cancer risk.

KEY WORDS: • O⁶-methylguanine • O⁶-alkylguanine DNA-alkyltransferase • MGMT • K-ras • colorectal cancer

This article has been cited by other articles:

				A. M.C.P. Joosen, G. G.C. Kuhnle, S. M. Aspinall, T. M. Barrow, E. Lecommandeur, A. Azqueta, A. R. Collins, and S. A. Bingham Effect of processed and red meat on endogenous nitrosation and DNA damage Carcinogenesis, August 1, 2009; 30(8): 1402 - 1407. [Abstract] [Full Text] [PDF]

				R. Xiao, Y. Su, R. C. M. Simmen, and F. A. Simmen Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G868 - G876. [Abstract] [Full Text] [PDF]

				W. M Grady and C. M Ulrich DNA alkylation and DNA methylation: cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas? Gut, March 1, 2007; 56(3): 318 - 320. [Full Text] [PDF]

				L. Shen, Y. Kondo, G. L. Rosner, L. Xiao, N. S. Hernandez, J. Vilaythong, P. S. Houlihan, R. S. Krouse, A. R. Prasad, J. G. Einspahr, et al. MGMT Promoter Methylation and Field Defect in Sporadic Colorectal Cancer J Natl Cancer Inst, September 21, 2005; 97(18): 1330 - 1338. [Abstract] [Full Text] [PDF]

				M. M. Huycke and H. R. Gaskins Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597. [Abstract] [Full Text] [PDF]